Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
Public ClinicalTrials.gov record NCT07150845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults With Atopic Dermatitis
Study identification
- NCT ID
- NCT07150845
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
- Last update posted
- May 17, 2026
2025 – 2026
United States locations
- U.S. sites
- 24
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Saguaro Dermatology | Phoenix | Arizona | 85008 | — |
| Center for Dermatology Clinical Research | Fremont | California | 94538 | — |
| Metropolis Dermatology - Downtown Los Angeles | Los Angeles | California | 90017 | — |
| Skin and Beauty Center | Pasadena | California | 91105 | — |
| Skin Care Research, LLC | Boca Raton | Florida | 33486 | — |
| Driven Research, LLC | Coral Gables | Florida | 33134 | — |
| Skin Care Research - Hollywood Dermatology | Hollywood | Florida | 33021 | — |
| TrueBlue Clinical Research | Tampa | Florida | 33609 | — |
| DS Research | Clarksville | Indiana | 47129 | — |
| Equity Medical | Bowling Green | Kentucky | 42104 | — |
| Aesthetic and Dermatology Center | Rockville | Maryland | 20850 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | — |
| Michigan Dermatology Institute | Waterford | Michigan | 48328 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64507 | — |
| Empire Dermatology | East Syracuse | New York | 13057 | — |
| Equity Medical | New York | New York | 10023 | — |
| Skin Search of Rochester, Inc. | Rochester | New York | 14623 | — |
| Wilmington Dermatology Center | Wilmington | North Carolina | 28405 | — |
| DOCS Dermatology Clinical Research | Canal Winchester | Ohio | 43110 | — |
| International Clinical Research - Murfreesboro | Murfreesboro | Tennessee | 37130 | — |
| Stryde Research | Lewisville | Texas | 75056 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Jordan Valley Dermatology Center | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07150845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07150845 live on ClinicalTrials.gov.